|
|
λ GENETIC NETWORKS & λ RED-MEDIATED RECOMBINATION
|
Z01 BC 010336
|
$806,353
|
$120,953
|
Court, Donald
|
CCR (NCI)
|
|
|
28th International Herpesvirus Workshop,
|
5R13CA102553-05
|
$14,223
|
$2,845
|
NELSON, JAY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
A Mouse Model for Prostate Cancer
|
5U01CA084294-09
|
$1,212,233
|
$121,223
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-03
|
$280,899
|
$28,090
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Phase I Trial of CCL-21 Gene Modified DC in NSCLC
|
5R21CA105705-02
|
$331,634
|
$331,634
|
Dubinett, Steven
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A transmembrane collagen induced in prostate cancer
|
5R01CA104973-04
|
$262,798
|
$26,280
|
ZETTER, BRUCE
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
A Tumor Specific Therapy Approach for Small Cell Lung Cancer
|
5R21CA104297-02
|
$122,501
|
$122,501
|
ZOU, YIYU
|
YESHIVA UNIVERSITY
|
|
|
Acetyltransferases in Transformation by c-MYC
|
3R01CA090465-06S1
|
$61,157
|
$6,116
|
MCMAHON, STEVEN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Ad5-TRIAL gene therapy for prostate cancer
|
5R21CA110486-02
|
$122,982
|
$122,982
|
Williams, Richard
|
UNIVERSITY OF IOWA
|
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-02
|
$298,169
|
$298,169
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
|
ALPHAV INTEGRINS AND TUMOR ANGIOGENESIS
|
5R37CA050286-19
|
$443,508
|
$110,877
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Altered Proteoglycan Gene Expression and Cancer
|
5R01CA039481-22
|
$373,046
|
$74,609
|
IOZZO, RENATO
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
An Ets2 dependent stromal restriction of breast cancer
|
5R01CA098778-05
|
$324,050
|
$81,013
|
OSHIMA, ROBERT
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
Analyzing Hepatitis B Virus Pathogenesis
|
5R01CA023931-29
|
$325,999
|
$97,800
|
Isom, Harriet
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
|
Animal Model for Her-2/neu Specific TCR Gene Transfer
|
5R01CA102280-06
|
$263,355
|
$263,355
|
NISHIMURA, MICHAEL
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Anti-CD20 CTL for Therapy of Mantle Cell Lymphoma
|
5R21CA117131-02
|
$286,141
|
$71,535
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Anti-Idiotype Therapy of Human B Cell Malignancy
|
5R37CA033399-26
|
$594,988
|
$297,494
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
|
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers
|
1R01CA114340-01A2
|
$251,037
|
$251,037
|
RAMAKRISHNAN, SUNDARAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Antibody-modified adenoviral vectors for tumor targeting
|
5R01CA098160-05
|
$295,881
|
$295,881
|
LI, ERGUANG
|
SCRIPPS RESEARCH INSTITUTE
|
|
|
Antigen Specific Immunotherapy with Transduced HSC
|
5R01CA100483-05
|
$344,936
|
$172,468
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-02
|
$256,507
|
$64,127
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
|
ARHI (NOEY2), an imprinted breast cancer suppressor gene
|
7R01CA080957-07
|
$179,550
|
$44,888
|
YU, YINHUA
|
FUDAN UNIVERSITY
|
|
|
Armed Replicating Ad for Breast Cancer Bone Metastasis
|
5R01CA108585-02
|
$225,695
|
$112,848
|
Douglas, Joanne
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Astrocytic Cancers: How, When, Where?
|
5U01CA084314-09
|
$1,087,426
|
$217,485
|
VAN DYKE, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Autoimmune vitiligo as a roadmap to melanoma therapy
|
5R01CA109536-03
|
$222,472
|
$88,989
|
Le Poole, Isabelle
|
LOYOLA UNIVERSITY CHICAGO
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$4,800
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Biological and genetic analysis of Fish, a Src substrate
|
5R01CA098383-05
|
$321,798
|
$32,180
|
COURTNEIDGE, SARA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-13
|
$2,065,942
|
$1,549,457
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Biology of the Immune Response
|
Z01 SC 004017
|
$650,421
|
$32,521
|
Nelson, David
|
CCR (NCI)
|
|
|
Bone Marrow Transplantation in Human Disease
|
2P01CA015396-32A1
|
$2,857,642
|
$285,764
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
|
BRAIN TUMOR SPORE GRANT
|
2P50CA097257-06
|
$2,252,869
|
$112,643
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
BRAIN TUMOR SPORE GRANT
|
3P50CA097257-06S1
|
$50,000
|
$2,500
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Brain Tumor Stem Cell-targeted Gene Therapy
|
5R41CA126014-02
|
$74,296
|
$74,296
|
Ohlfest, John
|
DISCOVERY GENOMICS, INC.
|
|
|
Breast Cancer Biology of Translational De-repression
|
7R01CA063640-11
|
$237,108
|
$237,108
|
HAGEDORN, CURT
|
UNIVERSITY OF UTAH
|
|
|
c-Myc, growth factor and breast cancer
|
5R01CA100864-06
|
$316,413
|
$79,103
|
LIAO, DEZHONG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Cancer and Leukemia Group B
|
5U10CA032291-26
|
$333,194
|
$23,324
|
WINER, ERIC
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer and Leukemia Group B
|
5U10CA047577-20
|
$160,142
|
$11,210
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
|
Cancer and Leukemia Group B
|
5U10CA077597-10
|
$113,805
|
$7,966
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
|
CANCER AND LEUKEMIA GROUP B
|
5U10CA077651-10
|
$264,314
|
$18,502
|
Hudis, Clifford
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Cancer and Leukemia Group B
|
5U10CA041287-22
|
$266,860
|
$18,680
|
FLEMING, GINI
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
3U10CA031946-26S2
|
$450,000
|
$31,500
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
5U10CA031946-26
|
$10,080,981
|
$705,669
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
5U10CA037447-24
|
$1,615,920
|
$64,637
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
5U10CA047559-17
|
$118,078
|
$8,265
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Cancer and Leukemia Group B
|
5U10CA003927-50
|
$247,998
|
$17,360
|
HURD, DAVID
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-10
|
$434,962
|
$30,447
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-28
|
$5,064,881
|
$354,542
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
|
Cancer and Leukemia Group B-Leukemia Correlative Science
|
5U10CA101140-05
|
$994,868
|
$69,641
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
5U10CA059518-15
|
$326,269
|
$22,839
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Cancer Immunotherapy Targeting Endothelial Antigens
|
5R01CA098637-06
|
$286,084
|
$100,129
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Total relevant funding to Gene Therapy for this search: $86,063,332
|
